Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06016920
Status:
RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-08-24
Brief Title:
Safety and Efficacy of VB1016 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
Sponsor:
Nykode Therapeutics ASA
Organization:
Nykode Therapeutics ASA